Grandview Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Grandview Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,319	Closed	-$200K	–	143
2025 Q2	$200K	Sell	4,319 -562	-12%	-$27.6K	0.06%	134
2025 Q1	$298K	Buy	4,881 +19	+0.4%	+$1.11K	0.11%	101
2024 Q4	$275K	Buy	+4,862	New	+$272K	0.1%	103
2024 Q2	–	Sell	-5,687	Closed	-$308K	–	61
2024 Q1	$308K	Sell	5,687 -34	-0.6%	-$1.73K	0.14%	88
2023 Q4	$294K	Sell	5,721 -1,975	-26%	-$104K	0.15%	86
2023 Q3	$447K	Buy	+7,696	New	+$472K	0.26%	70
2023 Q2	–	Sell	-8,156	Closed	-$565K	–	67
2023 Q1	$565K	Sell	8,156 -757	-8%	-$53.4K	0.33%	64
2022 Q4	$641K	Buy	8,913 +2	+0%	+$151	0.4%	59
2022 Q3	$633K	Sell	8,911 -630	-7%	-$45.7K	0.4%	60
2022 Q2	$735K	Buy	9,541 +344	+4%	+$26.2K	0.41%	57
2022 Q1	$672K	Sell	9,197 -206	-2%	-$13.8K	0.28%	67
2021 Q4	$586K	Buy	+9,403	New	+$552K	0.24%	78
2021 Q3	–	Sell	-15,484	Closed	-$1.03M	–	70
2021 Q2	$1.03M	Sell	15,484 -7,641	-33%	-$498K	0.57%	46
2021 Q1	$1.46M	Sell	23,125 -3,057	-12%	-$190K	0.78%	36
2020 Q4	$1.62M	Sell	26,182 -613	-2%	-$37.7K	1.06%	29
2020 Q3	$1.61M	Sell	26,795 -2,632	-9%	-$158K	1.31%	21
2020 Q2	$1.73M	Buy	+29,427	New	+$1.76M	1.51%	19

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Grandview Asset Management's BMY Position: Q3 2025 in Review

Grandview Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 4,319 shares — an estimated $200K sold.

Grandview Asset Management first reported a position in BMY in Q2 2020 and held it in 17 quarters. The position peaked at $1.73M in Q2 2020. 2,274 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

Grandview Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
Grandview Asset Management sold 4,319 Bristol-Myers Squibb shares in Q3 2025, an estimated $200K.
Grandview Asset Management first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 17 quarters.
Grandview Asset Management's Bristol-Myers Squibb position peaked at $1.73M in Q2 2020.
2,274 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Grandview Asset Management's 13F filing for Q3 2025, filed 22 Oct 2025.